Scopoletin: A Validated Protector against Cerulein-induced Acute Pancreatitis & Associated Lung Injury by Regulating...

Area of Science:

• Pharmacology
• Molecular Biology
• Gastroenterology

Background:

• Previous studies show scopoletin (SC) protects against cerulein-induced acute pancreatitis (AP) and pulmonary injury.
• The exact molecular pathways of SC's protective effects in AP remain unclear.

Purpose of the Study:

• To investigate the molecular mechanisms of SC's anti-inflammatory effects in experimental AP.
• To determine if SC activates peroxisome proliferator-activated receptor gamma (PPAR-γ) signaling.

Main Methods:

• In vivo study using male Swiss mice with cerulein-induced AP, treated with SC and/or PPAR-γ antagonist GW9662.
• In vitro assessment of SC's effect on pancreatic acinar cells with GW9662.
• Molecular docking and simulation to analyze SC-PPAR-γ interactions.

Main Results:

• SC administration reduced pro-inflammatory cytokines and NF-κB release in AP mice.
• SC (25 µM) enhanced phagocytic clearance of dying acinar cells via PPAR-γ activation.
• GW9662 counteracted SC's beneficial effects in vitro, and molecular docking showed SC alters PPAR-γ structure.

Conclusions:

• SC exhibits potent anti-inflammatory properties in experimental AP.
• SC-mediated protection is likely achieved through the activation of PPAR-γ signaling.
• SC demonstrates therapeutic potential for managing acute pancreatitis.